BAOJ Cellular & Molecular Cardiology

Bioaccent Online Publishing

About the Journal

The BAOJ Cellular & Molecular Cardiology publishes the latest findings in Cardiology. The aim of the journal is to publish the highest quality and most reliable information in cardiovascular medicine. It is a comprehensive medical magazine having topics on all disciplines of cardiology. It provides readers with genuine basic and clinical research articles on all facets of cardiovascular disease.

The BAOJ Cellular & Molecular Cardiology includes articles on a huge range of topics in cardiology, such as:

  • Cardiomyopathy
  • Ischemic heart disease
  • Valvular heart disease
  • Hypertension
  • vascular disease
  • Arrhythmia
  • Pharmacological healing
  • Congenital heart disease
  • Non-pharmacological treatment
  • Cardiovascular imaging
  • New diagnostic techniques

The journal publishes an assortment of clinical trials, review articles, short communications, latest research works and imperative letters and messages to the editor, as well.

The BAOJ Cellular & Molecular Cardiology journal has an Open Archive. It means that all articles of the magazine are made freely available to readers online after their publication. This open-access journal is dedicated to cardiology in the widest sense, as it publishes only trusted and genuine clinical and research studies and their findings. It is considered the most preferred publication among all levels of researchers and clinicians.

The journal of BAOJ Cellular & Molecular Cardiology launches a range of new types of manuscripts, besides original papers, including:

  • Papers on Consensus and Position
  • Meta-analyses
  • Systematic Reviews
  • Short communications

In the journal, readers can also find active discussions on controversial techniques of cardiology. As issues on social medicine and health policy are discussed, this cardiology journal of BAOJ serves as a handy tool for debates.

Published content is freely available to the readers across the world. No subscription required. Latest scientific information is available in PDF and HTML formats.

Impact Factor: 1.4
  • Adult Cardiology
  • Angioplasty
  • Aortic Valve Replacement
  • Arrhythmias
  • Atherosclerosis
  • Cardiac Anesthesia
  • Cardiac Arrest
  • Cardiac Biomarkers
  • Cardiac Examination
  • Cardiac Stem Cells
  • Cardiopulmonary Disorders
  • Cardiothoracic Surgery
  • Cardiovascular Gene Therapy
  • Clinical Cardiology
  • Congenital Heart Defects
  • Congenital Heart Disease
  • Coronary Artery Diseases
  • Coronary Stent
  • CV Imaging
  • Echocardiography
  • Electrophysiology
  • Heart Diseases
  • Heart Disorders
  • Heart Failure
  • Heart Surgery
  • Heart Transplants
  • Hypertension
  • Interventional Cardiology
  • Myocardial Infarction
  • Myocardial Ischemia
  • Pericarditis
  • Peripheral Vascular Disease
  • Arrhythmias
  • Cardiac Electrophysiology
  • Cardiac Surgery
  • Cardiovascular Biology
  • Heart Failure
  • Pediatric Cardiology
  • Preventative Cardiology
  • Valvular Heart Disease

Latest Articles

Anti-atherogenic effect and cardiovascular benefit of GLP-1 receptor agonists

Overweight and obesity are currently among the most important risk factors: an increase in BMI of 5 kg/m2 leads to a 30% increase in overall mortality and a 40% increase in vascular mortality for coronary heart disease, cerebrovascular diseases, and other vascular diseases. ...

Simultaneous Analysis of Global and Regional Left Atrial Function Using Three-Dimensional Speckle-Tracking Echocardiography

Accurate and reliable quantitative evaluation of LA size and function are necessary for the diagnosis and treatment of heart disease and prediction of prognosis. ...

Myocardial Regeneration: A Novell Multifaceted Strategic Approach

Myocardial infarction and cardiac failure is a major source of morbidity and mortality globally. Current treatment strategies are mostly palliative and suboptimal. Stem cell based treatment strategy for tissue regeneration has proven value in the treatment of some conditions. The optimal treatment of myocardial infarction/heart failure lays in restoration and maintenance of adequate functional myocardial syntitium. ...

Retrograde Cellular Cardiomyoplasty through the Coronary Sinus. An Experimental Study on Swines

The aim was to create a model of myocardial infarction (MI) with a borderline myocardial impairment which would enable to evaluate the retrograde cellular cardiomyoplasty (CCM) through the coronary sinus (CS) in a large animal model. ...